Heart failure hope: could a weight loss shot ease strain on the heart?
NCT ID NCT05371496
Summary
This study is testing if semaglutide, a medication used for weight loss, can improve heart function and symptoms in obese patients with a specific type of heart failure where the heart pumps normally but doesn't relax well. About 81 participants with obesity and this heart condition will receive either the drug or a placebo to see if aggressive weight loss helps their hearts work better during exercise and improves their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.